Back to search

Article

Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183

2021-05-14

Abstract excerpt

Drug resistance and a dire lack of transmission-blocking antimalarials hamper malaria elimination. Here, we present the pantothenamide MMV693183 as a first-in-class acetyl-CoA synthetase (ACS) inhibitor to enter preclinical development. Our studies demonstrated attractive drug-like properties and in vivo efficacy in a humanized mouse model of Plasmodium falciparum infection. The compound showed exceptional in v...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b1c65339-302b-5b85-a9b3-d06d9098ad64
DOI
10.1101/2021.05.12.443866
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Preclinical characterization and target validation of the antimalarial pantothenamide MMV693183DOI 10.1101/2021.05.12.443866
Select a neighboring publication to make it the new centre.